Dr Ed Penhoet joins Veloxis Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Veloxis Pharmaceuticals, which changed its name from LifeCyclePharma, has also appointed Dr Ed Penhoet to its board of directors. Dr Penhoet was recently appointed to President Obama's Council of Advisors on Science and Technology. He was co-founder, president and CEO of Chiron, and sits on the board of several life sciences companies, including ChemoCentryx and Metabolex, and the venture capital firm, Alta Partners.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.